<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Cancer</journal-id>
      <journal-title>BMC Cancer</journal-title>
      <issn pub-type="epub">1471-2407</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">16042772</article-id>
      <article-id pub-id-type="pmc">1181810</article-id>
      <article-id pub-id-type="publisher-id">1471-2407-5-85</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2407-5-85</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Zollinger-Ellison syndrome associated with neurofibromatosis type 1: a case report</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" corresp="yes" contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Wan-Sik</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>jadelook@chol.com</email>
        </contrib>
        <contrib id="A2" contrib-type="author">
          <name>
            <surname>Koh</surname>
            <given-names>Yang-Seok</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>Koh88@dreamwiz.com</email>
        </contrib>
        <contrib id="A3" contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Jung-Chul</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>3rdvivace@hanmail.net</email>
        </contrib>
        <contrib id="A4" contrib-type="author">
          <name>
            <surname>Park</surname>
            <given-names>Chang-Hwan</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>p1052ccy@hanmail.net</email>
        </contrib>
        <contrib id="A5" contrib-type="author">
          <name>
            <surname>Joo</surname>
            <given-names>Young-Eun</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>yejoo@chonnam.ac.kr</email>
        </contrib>
        <contrib id="A6" contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Hyun-Soo</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>dshskim@chonnam.ac.kr</email>
        </contrib>
        <contrib id="A7" contrib-type="author">
          <name>
            <surname>Cho</surname>
            <given-names>Chol-Kyoon</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>ckcho@chonnam.ac.kr</email>
        </contrib>
        <contrib id="A8" contrib-type="author">
          <name>
            <surname>Choi</surname>
            <given-names>Sung-Kyu</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>choisk@chonnam.ac.kr</email>
        </contrib>
        <contrib id="A9" contrib-type="author">
          <name>
            <surname>Rew</surname>
            <given-names>Jong-Sun</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>jsrew@chonnam.ac.kr</email>
        </contrib>
        <contrib id="A10" contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Sei-Jong</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>hepakim@chonnam.ac.kr</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Division of Gastroenterology, Department of Internal Medicine, Chonnam University Medical School, Hak-dong 8, Donggu, Gwangju, Korea</aff>
      <aff id="I2"><label>2</label>Department of Surgery, Chonnam University Medical School. Hak-dong 8, Donggu, Gwangju, Korea</aff>
      <pub-date pub-type="collection">
        <year>2005</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>21</day>
        <month>7</month>
        <year>2005</year>
      </pub-date>
      <volume>5</volume>
      <fpage>85</fpage>
      <lpage>85</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2407/5/85"/>
      <history>
        <date date-type="received">
          <day>3</day>
          <month>4</month>
          <year>2005</year>
        </date>
        <date date-type="accepted">
          <day>21</day>
          <month>7</month>
          <year>2005</year>
        </date>
      </history>
      <copyright-statement>Copyright &#xA9; 2005 Lee et al; licensee BioMed Central Ltd.</copyright-statement>
      <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
        <p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
      </license>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Neurofibromatosis type 1 is an autosomal dominant neurocutaneous disorder with characteristic features of skin and central nervous system involvement. Gastrointestinal involvement is rare, but the risk of malignancy development is considerable. Zollinger-Ellison syndrome is caused by gastrin-secreting tumors called gastrinomas. Correct diagnosis is often difficult, and curative treatment can only be achieved surgically.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>A 41-year-old female affected by neurofibromatosis type 1 presented with a history of recurrent epigastric soreness, diarrhea, and relapsing chronic duodenal ulcer. Her serum fasting gastrin level was over 1000 pg/mL. An abdominal CT scan revealed a 3 &#xD7; 2-cm, well-enhanced mass adjacent to the duodenal loop. She was not associated with multiple endocrine neoplasia type 1. Operative resection was performed and gastrinoma was diagnosed by immunohistochemical staining. The serum gastrin level decreased to 99.1 pg/mL after surgery, and symptoms and endoscopic findings completely resolved without recurrences.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Gastrinoma is difficult to detect even in the general population, and hence symptoms such as recurrent idiopathic peptic ulcer and diarrhea in neurofibromatosis type 1 patients should be accounted for as possibly contributing to Zollinger-Ellison syndrome.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Neurofibromatosis type 1 (NF1) is an autosomal dominant neurocutaneous disorder with an estimated prevalence of 2 to 3 cases per 10,000 population [<xref ref-type="bibr" rid="B1">1</xref>]. NF1 is characterized by neurocutaneous signs such as caf&#xE9;-au-lait spots, axillary freckling, and cutaneous neurofibromas. Cognitive deficits and academic learning difficulties are the most common neurological complications of NF1 in childhood. Moreover, patients with NF1 are at an increased risk of developing nervous system neoplasms. Malignancy other than of nervous system origin can develop, with the prevalence of such malignant tumors reportedly being four times higher in NF1 patients than in the general population [<xref ref-type="bibr" rid="B2">2</xref>]. Gastrointestinal malignancy was reported to be associated with NF1 patients, with neuroendocrine tumors being the most prevalent [<xref ref-type="bibr" rid="B3">3</xref>]. However, there have been only one report about gastrinoma associated with NF1.</p>
      <p>Zollinger-Ellison syndrome (ZES) is characterized by hypersecretion of gastrin from a gastrinoma that leads to gastric acid hypersecretion and, most notably, clinical symptoms of refractory peptic ulcer disease. Zollinger and Ellison were the first to report recurrent peptic ulcers of the jejunum associated with nonbeta islet cell tumors of the pancreas [<xref ref-type="bibr" rid="B4">4</xref>]. The diagnosis is based on a combination of criteria, including clinical presentation, serum gastrin level, acid-secretion test, and diagnostic imaging studies. Improvements in medical management using proton-pump inhibitors mean that gastric acid hypersecretion can be effectively controlled in most cases. Determining the presence of metastasis to regional lymph nodes or the liver to monitor malignant progression is important before definitive treatment. ZES in the form of multiple endocrine neoplasia type 1 (MEN1) needs special consideration, since the disease progression, presentation, and treatment differ from those in the sporadic form [<xref ref-type="bibr" rid="B5">5</xref>].</p>
      <p>In this report, we describe a patient with NF1 who was diagnosed as ZES and successfully treated by curative surgery.</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <p>A 41-year-old female NF1 patient was admitted for the evaluation of a 3-year history of recurrent epigastric soreness, heartburn, and diarrhea. Repeated endoscopic examinations revealed recurrent duodenal ulcers. The symptoms were relieved by proton-pump inhibitors, but recurred when the medication was withdrawn. She was previously diagnosed with NF1 based on clinical features and family history. Her first-degree relatives (i.e., brother, sister, and second son) were also affected by fully developed features of NF1. She had no cognitive dysfunction or learning disabilities, and showed normal intellectual development. A physical examination revealed several caf&#xE9;-au-lait spots and multiple small nodules on the anterior chest and areolar area, and also multiple axillary freckles. A skin-nodule biopsy demonstrated characteristic neurofibromas.</p>
      <p>On admission, upper gastrointestinal endoscopy revealed multiple shallow ulcers in the descending duodenum. The rapid urease test and urea breath test for <italic>Helicobacter pylori </italic>were both negative. The serum fasting gastrin level was &gt;1,000 pg/mL and 837 pg/mL in two consecutive measurements. A secretin stimulation test was not performed due to the unavailability of secretin. As a diagnosis of gastrinoma was strongly suggested, radiologic evaluations were performed to locate the lesion. Abdominal computed tomography (CT) and magnetic resonance imaging (MRI) scans showed a 3 &#xD7; 2-cm, clearly defined, well-enhanced mass adjacent to the duodenal loop in the subhepatic space (Figure <xref ref-type="fig" rid="F1">1</xref>). No metastatic lesions were observed in the liver or regional lymph nodes.</p>
      <p>The association with MEN1 status was evaluated by hormonal and radiologic investigations of the parathyroid, pituitary, pancreas, and adrenal gland, which proved to be negative. As a definitive treatment, an intraabdominal mass of about 2.5 &#xD7; 2 cm with a thick fibrous capsular outer layer was surgically isolated and completely resected from the right lateral border of the descending duodenum. Gastrinoma was finally diagnosed by immunohistochemical staining (Figures <xref ref-type="fig" rid="F2">2</xref>, <xref ref-type="fig" rid="F3">3</xref>). An incidental finding during the operation was numerous, small (&lt;1.0 cm), whitish nodular masses on the serosal surface of the small bowel, many of which were enucleated. The pathologic diagnosis was gastrointestinal stromal tumor (GIST) with a low mitotic index as evidenced by C-kit positivity (Figures <xref ref-type="fig" rid="F4">4</xref>, <xref ref-type="fig" rid="F5">5</xref>). The serum gastrin level decreased markedly to 99.1 pg/mL at 1 month after the operation, and to 53.2 pg/mL 3 months later. There were no symptomatic or radiologic recurrences during a 14-month follow up.</p>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>NF1 is an autosomal dominant single-gene disorder with an estimated prevalence of 2 to 3 cases per 10,000 population [<xref ref-type="bibr" rid="B1">1</xref>]. NF1 is characterized by neurocutaneous signs, such as caf&#xE9;-au-lait spots, axillary freckling, and cutaneous neurofibromatosis, and iris hamartomas [<xref ref-type="bibr" rid="B6">6</xref>]. Neurofibromas are benign peripheral nerve tumors composed of proliferating Schwann cells and fibroblasts. They present as multiple palpable, rubbery cutaneous tumors, and are generally asymptomatic.</p>
      <p>In our case, the diagnosis of NF1 was established based on characteristic clinical features including dermatologic findings, pathological diagnosis of neurofibroma, and familial history of NF1 in first-degree relatives. These fulfilled the diagnostic criteria of NF1, and so further genetic testing was considered unnecessary [<xref ref-type="bibr" rid="B6">6</xref>]. There was a possibility that the skin lesions were associated with the MEN1 and that the gastrinoma occurred in the context of MEN1. However, meticulous laboratory and radiologic investigations indicated that the patient was not affected by MEN1.</p>
      <p>NF1 patients have mutations of the NF1 gene on chromosome 17 [<xref ref-type="bibr" rid="B7">7</xref>]. The NF1 gene is a tumor-suppressor gene encoding a protein, neurofibromin, which functions in normal cells as a suppressor of the ras signaling cascades [<xref ref-type="bibr" rid="B8">8</xref>].</p>
      <p>The development of malignancy in NF1 is frequently encountered, and can influence the outcome [<xref ref-type="bibr" rid="B9">9</xref>]. The prevalence of malignant tumors is reportedly four times higher in NF1 patients than in the general population [<xref ref-type="bibr" rid="B2">2</xref>]. Patients with NF1 are at an increased risk of developing central nervous system tumors, including optic pathway gliomas and brainstem and cerebellar tumors [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B11">11</xref>].</p>
      <p>Gastrointestinal involvement in NF1 occurs at diverse locations, and its clinical features encompass variable manifestations including intestinal bleeding, ischemia, angina, infarction, and bowel obstruction [<xref ref-type="bibr" rid="B12">12</xref>-<xref ref-type="bibr" rid="B16">16</xref>]. A previous report suggested that gastrointestinal involvement in NF1 occurs as intestinal ganglioneuromas, GISTs, and carcinoids of the periampullary region of the duodenum that may be associated with pheochromocytoma [<xref ref-type="bibr" rid="B3">3</xref>].</p>
      <p>Several cases of gastrointestinal adenocarcinomas have been reported in literature [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B18">18</xref>], but the most common gastrointestinal malignancy in NF1 is neuroendocrine tumors in the upper gastrointestinal tract, characteristically in the periampullary region [<xref ref-type="bibr" rid="B19">19</xref>-<xref ref-type="bibr" rid="B21">21</xref>]. Many are classified as somatostatinomas [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B23">23</xref>], and NF1 has rarely been associated with insulinomas and gastrinomas [<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B25">25</xref>]. Our literature review revealed only one reported case of ZES associated with NF1, and hence the present case represents only the second reported case. The multiple small nodular tumors attached to the serosal surface of the small bowel observed during laparotomy in our patient were found to be stromal tumors with a low malignant potential. We assumed that these stromal tumors were an incidental finding that carried no current potential risk of developing into malignant GIST.</p>
      <p>Most patients with ZES initially present with abdominal pain, heartburn, diarrhea, and weight loss. These patients are often misdiagnosed as idiopathic peptic ulcer disease, resulting in a delayed true diagnosis that leads to a more advanced stage of the disease.</p>
      <p>The diagnosis of ZES is based on previously described criteria [<xref ref-type="bibr" rid="B26">26</xref>]. A fasting serum gastrin level of &gt;200 pg/mL should raise the suspicion of the disease, and a level of &gt;1000 pg/mL without the presence of achlorhydria secondary to atrophic gastritis is virtually indicative of ZES. Gastric secretory testing usually demonstrates the presence of a basal acid output of greater than 15 mEq in unoperated patients. The secretin stimulation test is a useful way to confirm the diagnosis of ZES (where the increase is &gt;200 pg/mL), when the fasting serum gastrin level is only modestly elevated and the diagnosis is in doubt [<xref ref-type="bibr" rid="B27">27</xref>]. Finally, a positive histologic confirmation of gastrinoma provides definitive evidence of the presence of ZES. In our case, an elevated level of gastrin and characteristic pathologic findings indicated the correct diagnosis of ZES.</p>
      <p>More than 80% of the tumors in ZES are located in the so-called gastrinoma triangle [<xref ref-type="bibr" rid="B28">28</xref>]. In addition, more than 90% of duodenal gastrinomas occur in the first or second portion of the duodenum, and about 50% of them are solitary [<xref ref-type="bibr" rid="B29">29</xref>]. In our case, the tumor was located in the extraduodenal space within the gastrinoma triangle.</p>
      <p>Various imaging methods are available for localizing a gastrinoma. In our patient, the tumor was detected by conventional CT and MRI scans as a isolated, well-contained mass without metastasis to the liver or lymph nodes, which enabled curative resection.</p>
    </sec>
    <sec>
      <title>Conclusion</title>
      <p>Most patients with NF1 never develop major complications, but the mainstay of care remains anticipatory guidance and surveillance for treatable complications. As in our case, NF1 can be related to neuroendocrine tumors that will progress if not managed early in the course of the disease. As accurate diagnosis of gastrinoma can be difficult, a high level of suspicion and timely evaluation should be applied to NF1 patients manifesting characteristic symptoms attributable to ZES.</p>
    </sec>
    <sec>
      <title>List of abbreviations used</title>
      <p>CT: computed tomography</p>
      <p>GIST: gastrointestinal stromal tumor</p>
      <p>MEN1: multiple endocrine neoplasia type 1</p>
      <p>MRI: magnetic resonance imaging</p>
      <p>NF1: neurofibromatosis type 1</p>
      <p>ZES: Zollinger-Ellison syndrome</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The author(s) declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p>CHP, YEJ, HSK, SKC, JSR, and SJK made substantial contributions to the conception and interpretation of clinical data and case-related studies, and clinical decisions. YSK, JCK, and CKC performed the surgery and provided final diagnosis of the disease. All authors read and approved the final manuscript.</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2407/5/85/prepub"/>
      </p>
    </sec>
  </body>
  <back>
    <ack>
      <sec>
        <title>Acknowledgements</title>
        <p>Written consent was obtained from the patient for publication of the patient's details.</p>
      </sec>
    </ack>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Friedman</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Epidemiology of neurofibromatosis type I</article-title>
          <source>Am J Med Genet</source>
          <year>1999</year>
          <volume>89</volume>
          <fpage>1</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">10469430</pub-id>
          <pub-id pub-id-type="doi">10.1002/(SICI)1096-8628(19990326)89:1&lt;1::AID-AJMG3&gt;3.0.CO;2-8</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zoller</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rembeck</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Akesson</surname>
              <given-names>HO</given-names>
            </name>
            <name>
              <surname>Angervall</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Goteborg, Sweden</article-title>
          <source>Acta Derm Venereol</source>
          <year>1995</year>
          <volume>75</volume>
          <fpage>136</fpage>
          <lpage>140</lpage>
          <pub-id pub-id-type="pmid">7604643</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fuller</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>GT</given-names>
            </name>
          </person-group>
          <article-title>Gastrointestinal manifestations of type 1 neurofibromatosis (von Recklinghausen's disease)</article-title>
          <source>Histopathology</source>
          <year>1991</year>
          <volume>19</volume>
          <fpage>1</fpage>
          <lpage>11</lpage>
          <pub-id pub-id-type="pmid">1916682</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zollinger</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Ellison</surname>
              <given-names>EH</given-names>
            </name>
          </person-group>
          <article-title>Primary peptic ulceration of the jejunum associated with islet cell tumors of the pancreas</article-title>
          <source>Ann Surg</source>
          <year>1955</year>
          <volume>142</volume>
          <fpage>709</fpage>
          <lpage>728</lpage>
          <pub-id pub-id-type="pmid">13259432</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jensen</surname>
              <given-names>RT</given-names>
            </name>
          </person-group>
          <article-title>Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type I</article-title>
          <source>J Intern Med</source>
          <year>1998</year>
          <volume>243</volume>
          <fpage>447</fpage>
          <lpage>488</lpage>
          <pub-id pub-id-type="pmid">9681842</pub-id>
          <pub-id pub-id-type="doi">10.1046/j.1365-2796.1998.00281.x</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gutmann</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Aynsworth</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Carey</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Korf</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Marks</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pyeritez</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Rubenstein</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Visckochil</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2</article-title>
          <source>JAMA</source>
          <year>1997</year>
          <volume>278</volume>
          <fpage>51</fpage>
          <lpage>57</lpage>
          <pub-id pub-id-type="pmid">9207339</pub-id>
          <pub-id pub-id-type="doi">10.1001/jama.278.1.51</pub-id>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barker</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Wright</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Nguyen</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Cannon</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Fain</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Goldgar</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bishop</surname>
              <given-names>DT</given-names>
            </name>
            <name>
              <surname>Carey</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Baty</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Kivlin</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Willard</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Waye</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Greig</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Leinwand</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Nakamura</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>O'Connell</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Leppert</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Lalouel</surname>
              <given-names>J-M</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Skolnick</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17</article-title>
          <source>Science</source>
          <year>1987</year>
          <volume>236</volume>
          <fpage>1100</fpage>
          <lpage>1102</lpage>
          <pub-id pub-id-type="pmid">3107130</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gutmann</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Collins</surname>
              <given-names>FS</given-names>
            </name>
          </person-group>
          <article-title>Identification of the neurofibromatosis type 1 gene product</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1991</year>
          <volume>88</volume>
          <fpage>9658</fpage>
          <lpage>9662</lpage>
          <pub-id pub-id-type="pmid">1946382</pub-id>
        </citation>
      </ref>
      <ref id="B9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zoller</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Rembeck</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Oden</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Samuelsson</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Angervall</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population</article-title>
          <source>Cancer</source>
          <year>1997</year>
          <volume>79</volume>
          <fpage>2125</fpage>
          <lpage>2131</lpage>
          <pub-id pub-id-type="pmid">9179058</pub-id>
          <pub-id pub-id-type="doi">10.1002/(SICI)1097-0142(19970601)79:11&lt;2125::AID-CNCR9&gt;3.0.CO;2-N</pub-id>
        </citation>
      </ref>
      <ref id="B10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bilaniuk</surname>
              <given-names>LT</given-names>
            </name>
            <name>
              <surname>Molloy</surname>
              <given-names>PT</given-names>
            </name>
            <name>
              <surname>Zimmerman</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Phillips</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Vaughan</surname>
              <given-names>SN</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>GT</given-names>
            </name>
            <name>
              <surname>Sutton</surname>
              <given-names>LN</given-names>
            </name>
            <name>
              <surname>Needle</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Neurofibromatosis type 1: brain stem tumours</article-title>
          <source>Neuroradiology</source>
          <year>1997</year>
          <volume>39</volume>
          <fpage>642</fpage>
          <lpage>653</lpage>
          <pub-id pub-id-type="pmid">9335063</pub-id>
          <pub-id pub-id-type="doi">10.1007/s002340050484</pub-id>
        </citation>
      </ref>
      <ref id="B11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pollack</surname>
              <given-names>IF</given-names>
            </name>
            <name>
              <surname>Shultz</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Mulvihill</surname>
              <given-names>JJ</given-names>
            </name>
          </person-group>
          <article-title>The management of brainstem gliomas in patients with neurofibromatosis 1</article-title>
          <source>Neurology</source>
          <year>1996</year>
          <volume>46</volume>
          <fpage>1652</fpage>
          <lpage>1660</lpage>
          <pub-id pub-id-type="pmid">8649565</pub-id>
        </citation>
      </ref>
      <ref id="B12">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hochberg</surname>
              <given-names>FH</given-names>
            </name>
            <name>
              <surname>Dasilva</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Galdabini</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Richardson</surname>
              <given-names>EP</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>Gastrointestinal involvement in von Recklinghausen's neurofibromatosis</article-title>
          <source>Neurology</source>
          <year>1974</year>
          <volume>24</volume>
          <fpage>1144</fpage>
          <lpage>1151</lpage>
          <pub-id pub-id-type="pmid">4374669</pub-id>
        </citation>
      </ref>
      <ref id="B13">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Petersen</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Ferguson</surname>
              <given-names>DR</given-names>
            </name>
          </person-group>
          <article-title>Gastrointestinal neurofibromatosis</article-title>
          <source>J Clin Gastroenterol</source>
          <year>1984</year>
          <volume>6</volume>
          <fpage>529</fpage>
          <lpage>534</lpage>
          <pub-id pub-id-type="pmid">6439777</pub-id>
        </citation>
      </ref>
      <ref id="B14">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Melin</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Grotz</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Nivatvongs</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Gastrointestinal hemorrhage complicating systemic neurofibromatosis</article-title>
          <source>Am J Gastroenterol</source>
          <year>1994</year>
          <volume>89</volume>
          <fpage>1888</fpage>
          <lpage>1890</lpage>
          <pub-id pub-id-type="pmid">7942689</pub-id>
        </citation>
      </ref>
      <ref id="B15">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Martin</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Williamson</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>Abdominal tumours and neurofibromatosis</article-title>
          <source>Postgrad Med J</source>
          <year>1996</year>
          <volume>72</volume>
          <fpage>59</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="pmid">8746290</pub-id>
        </citation>
      </ref>
      <ref id="B16">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heuschkel</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Korf</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Schneider</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bousvaros</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Abdominal migraine in children with neurofibromatosis type 1: a case series and review of gastrointestinal involvement in NF1</article-title>
          <source>J Pediatr Gastroenterol Nutr</source>
          <year>2001</year>
          <volume>33</volume>
          <fpage>149</fpage>
          <lpage>154</lpage>
          <pub-id pub-id-type="pmid">11568515</pub-id>
          <pub-id pub-id-type="doi">10.1097/00005176-200108000-00010</pub-id>
        </citation>
      </ref>
      <ref id="B17">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Costi</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Caruana</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Sarli</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Violi</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Roncoroni</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Bordi</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Ampullary adenocarcinoma in neurofibromatosis type 1. Case report and literature review</article-title>
          <source>Mod Pathol</source>
          <year>2001</year>
          <volume>14</volume>
          <fpage>1169</fpage>
          <lpage>1174</lpage>
          <pub-id pub-id-type="pmid">11706080</pub-id>
          <pub-id pub-id-type="doi">10.1038/modpathol.3880454</pub-id>
        </citation>
      </ref>
      <ref id="B18">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Joo</surname>
              <given-names>YE</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Rew</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>SJ</given-names>
            </name>
          </person-group>
          <article-title>Primary duodenal adenocarcinoma associated with neurofibromatosis type 1</article-title>
          <source>J Gastroenterol</source>
          <year>2002</year>
          <volume>37</volume>
          <fpage>215</fpage>
          <lpage>219</lpage>
          <pub-id pub-id-type="pmid">11931536</pub-id>
          <pub-id pub-id-type="doi">10.1007/s005350200024</pub-id>
        </citation>
      </ref>
      <ref id="B19">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hough</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Davidson</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Von Recklinghausen's disease associated with gastrointestinal carcinoid tumors</article-title>
          <source>Cancer</source>
          <year>1983</year>
          <volume>51</volume>
          <fpage>2206</fpage>
          <lpage>2208</lpage>
          <pub-id pub-id-type="pmid">6406032</pub-id>
        </citation>
      </ref>
      <ref id="B20">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Usui</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Matsuda</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hirata</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ogura</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Shiraishi</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Somatostatinoma of the papilla of Vater with multiple gastrointestinal stromaltumors in a patient with von Recklinghausen's disease</article-title>
          <source>J Gastroenterol</source>
          <year>2002</year>
          <volume>37</volume>
          <fpage>947</fpage>
          <lpage>953</lpage>
          <pub-id pub-id-type="pmid">12483251</pub-id>
          <pub-id pub-id-type="doi">10.1007/s005350200159</pub-id>
        </citation>
      </ref>
      <ref id="B21">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Walther</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Herring</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Enquist</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Keiser</surname>
              <given-names>HR</given-names>
            </name>
            <name>
              <surname>Linehan</surname>
              <given-names>WM</given-names>
            </name>
          </person-group>
          <article-title>von Recklinghausen's disease and pheochromocytomas</article-title>
          <source>J Urol</source>
          <year>1999</year>
          <volume>162</volume>
          <fpage>1582</fpage>
          <lpage>1586</lpage>
          <pub-id pub-id-type="pmid">10524872</pub-id>
          <pub-id pub-id-type="doi">10.1097/00005392-199911000-00003</pub-id>
        </citation>
      </ref>
      <ref id="B22">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mao</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hanson</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Howard</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Von Recklinghausen's disease associated with duodenal somatostatinoma: contrast of duodenal versus pancreatic somatostatinomas</article-title>
          <source>J Surg Oncol</source>
          <year>1995</year>
          <volume>59</volume>
          <fpage>67</fpage>
          <lpage>73</lpage>
          <pub-id pub-id-type="pmid">7745981</pub-id>
        </citation>
      </ref>
      <ref id="B23">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cappelli</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Agosti</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Braga</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cumetti</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Gandossi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Rizzoni</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Agabiti Rosei</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Von Recklinghausen's neurofibromatosis associated with duodenal somatostatinoma. A case report and review of the literature</article-title>
          <source>Minerva Endocrinol</source>
          <year>2004</year>
          <volume>29</volume>
          <fpage>19</fpage>
          <lpage>24</lpage>
          <pub-id pub-id-type="pmid">15258554</pub-id>
        </citation>
      </ref>
      <ref id="B24">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fung</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Lam</surname>
              <given-names>KS</given-names>
            </name>
          </person-group>
          <article-title>Neurofibromatosis and insulinoma</article-title>
          <source>Postgrad Med J</source>
          <year>1995</year>
          <volume>71</volume>
          <fpage>485</fpage>
          <lpage>486</lpage>
          <pub-id pub-id-type="pmid">7567757</pub-id>
        </citation>
      </ref>
      <ref id="B25">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chagnon</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Barge</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Henin</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Blanc</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>[Recklinghausen's disease with digestive localizations associated with gastric acid hypersecretion suggesting Zollinger-Ellison syndrome]</article-title>
          <source>Gastroenterol Clin Biol</source>
          <year>1985</year>
          <volume>9</volume>
          <fpage>65</fpage>
          <lpage>69</lpage>
          <pub-id pub-id-type="pmid">3920107</pub-id>
        </citation>
      </ref>
      <ref id="B26">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fishbeyn</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Norton</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Benya</surname>
              <given-names>RV</given-names>
            </name>
            <name>
              <surname>Pisegna</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Venzon</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Metz</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Jensen</surname>
              <given-names>RT</given-names>
            </name>
          </person-group>
          <article-title>Assessment and prediction of long-term cure in patients with the Zollinger-Ellison syndrome: the best approach</article-title>
          <source>Ann Intern Med</source>
          <year>1993</year>
          <volume>119</volume>
          <fpage>199</fpage>
          <lpage>206</lpage>
          <pub-id pub-id-type="pmid">8323088</pub-id>
        </citation>
      </ref>
      <ref id="B27">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lamers</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Jansen</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Roeffen</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Secretin injection test in the diagnosis of gastrinoma</article-title>
          <source>Gastroenterology</source>
          <year>1981</year>
          <volume>80</volume>
          <fpage>1615</fpage>
          <lpage>1616</lpage>
          <pub-id pub-id-type="pmid">6262186</pub-id>
        </citation>
      </ref>
      <ref id="B28">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stabile</surname>
              <given-names>BE</given-names>
            </name>
            <name>
              <surname>Morrow</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Passaro</surname>
              <given-names>E</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>The gastrinoma triangle: operative implications</article-title>
          <source>Am J Surg</source>
          <year>1984</year>
          <volume>147</volume>
          <fpage>25</fpage>
          <lpage>31</lpage>
          <pub-id pub-id-type="pmid">6691547</pub-id>
          <pub-id pub-id-type="doi">10.1016/0002-9610(84)90029-1</pub-id>
        </citation>
      </ref>
      <ref id="B29">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Modlin</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Lawton</surname>
              <given-names>GP</given-names>
            </name>
          </person-group>
          <article-title>Duodenal gastrinoma: the solution to the pancreatic paradox</article-title>
          <source>J Clin Gastroenterol</source>
          <year>1994</year>
          <volume>19</volume>
          <fpage>184</fpage>
          <lpage>188</lpage>
          <pub-id pub-id-type="pmid">7806825</pub-id>
        </citation>
      </ref>
    </ref-list>
    <sec sec-type="display-objects">
      <title>Figures and Tables</title>
      <fig position="float" id="F1">
        <label>Figure 1</label>
        <caption>
          <p>Abdominal CT scan showing a 3 &#xD7; 2 cm, well-defined, uniformly enhanced mass adjacent to the duodenal loop.</p>
        </caption>
        <graphic xlink:href="1471-2407-5-85-1"/>
      </fig>
      <fig position="float" id="F2">
        <label>Figure 2</label>
        <caption>
          <p>The pathologic findings were of a well-encapsulated solid mass containing cells with a diffuse, trabecular growth pattern. (&#xD7;40, H&amp;E).</p>
        </caption>
        <graphic xlink:href="1471-2407-5-85-2"/>
      </fig>
      <fig position="float" id="F3">
        <label>Figure 3</label>
        <caption>
          <p>The tumor cells were strongly immunopositive for gastrin. (&#xD7;250, avidin-biotin-peroxidase).</p>
        </caption>
        <graphic xlink:href="1471-2407-5-85-3"/>
      </fig>
      <fig position="float" id="F4">
        <label>Figure 4</label>
        <caption>
          <p>Biopsy of the multiple small nodules revealed the haphazard arrangement of uniform spindle cells in a collagenous stroma. (&#xD7;100, H &amp;E).</p>
        </caption>
        <graphic xlink:href="1471-2407-5-85-4"/>
      </fig>
      <fig position="float" id="F5">
        <label>Figure 5</label>
        <caption>
          <p>The tumor cells were immunopositive for C-kit (CD117). (&#xD7; 100, H &amp;E).</p>
        </caption>
        <graphic xlink:href="1471-2407-5-85-5"/>
      </fig>
    </sec>
  </back>
</article>
</pmc-articleset>
